Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Dingjiaqiao No. 87, Nanjing, China.
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing, China.
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618787386. doi: 10.1177/1753466618787386.
Although step counters are popularly employed for physical rehabilitation in chronic obstructive pulmonary disease (COPD) patients, their effectiveness is inconsistent and even questioned. This meta-analysis aimed to investigate whether step counter use increases physical activity or improves exercise capacity in COPD patients.
Electronic databases were searched for randomized controlled trials that assessed the efficacy of step counter use in increasing physical activity or in improving exercise capacity. Data were aggregated using a random-effects model to get the overall effect sizes [standard mean difference (SMD) with 95% confidence interval (CI)], and subgroup analyses were performed.
A total of 15 trials enrolling 1316 patients with moderate to severe COPD were included. Step counter use increased physical activity compared with controls (SMD = 0.57, 95% CI 0.31-0.84), which is equal to a magnitude of 1026 steps/day in daily steps. It also enhanced exercise capacity with an effect size of 0.30 (95% CI 0.16-0.45), approximating to a magnitude of 11.6 m in the 6-min walking distance. Step counter use could augment physical activity (SMD = 0.64, 95% CI 0.19-1.08) and exercise capacity (SMD = 0.32, 95% CI 0.01-0.62) for patients receiving pulmonary rehabilitation. Yet it cannot enhance physical activity or exercise capacity in patients with severe COPD or among studies with intervention durations ⩾6 months (both p > 0.50).
Step counter use increases physical activity and improves exercise capacity in COPD patients, at least in the short term, which supports the notion of recommending step counter use in COPD management.
虽然计步器在慢性阻塞性肺疾病(COPD)患者的物理康复中被广泛应用,但它们的有效性并不一致,甚至受到质疑。本荟萃分析旨在研究计步器的使用是否能增加 COPD 患者的身体活动量或改善其运动能力。
检索评估计步器使用对增加身体活动量或改善运动能力的疗效的随机对照试验的电子数据库。使用随机效应模型汇总数据以获得总体效应大小[标准均数差(SMD)及 95%置信区间(CI)],并进行亚组分析。
共纳入 15 项纳入中至重度 COPD 患者的 1316 例患者的试验。与对照组相比,计步器的使用增加了身体活动量(SMD = 0.57,95%CI 0.31-0.84),这相当于每天增加 1026 步。它还增强了运动能力,效应量为 0.30(95%CI 0.16-0.45),相当于 6 分钟步行距离增加 11.6 米。对于接受肺康复的患者,计步器的使用可以增加身体活动量(SMD = 0.64,95%CI 0.19-1.08)和运动能力(SMD = 0.32,95%CI 0.01-0.62)。然而,它不能增强重度 COPD 患者或干预持续时间 ⩾6 个月(两者 p > 0.50)的患者的身体活动量或运动能力。
计步器的使用可以增加 COPD 患者的身体活动量和改善其运动能力,至少在短期内是如此,这支持在 COPD 管理中推荐使用计步器的观点。